Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma crawled date : 2022 - 10 - 03 save search
PaxMedica Appoints Specialty Pharma Industry Leader Charles J. Casamento to Its Board of Directors
Published: 2022-10-03 (Crawled : 14:00) - biospace.com/
FWBI | $2.93 3.17% 17K
|
Manufacturing
|
| O: -4.73%
H: 21.99%
C: 15.6%
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -0.6%
H: 0.05%
C: -0.66%
RLMD | $4.22 -1.86% 11K
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: -4.99%
PXMD | $0.7406 -2.95% 180K
|
Health Technology
|
| O: 1.25%
H: 0.45%
C: -7.0%
ETON | $3.06 9.5K
|
Health Technology
|
| O: 1.9%
H: 0.93%
C: -0.93%
pharma
Silo Pharma Initiates FDA Pre-Investigational New Drug (IND) Package for Time-Released Ketamine Technology
Published: 2022-10-03 (Crawled : 14:00) - globenewswire.com
SILO | $1.96 -0.51% 580
|
Finance and Insurance
|
| O: 6.88%
H: 13.04%
C: -3.65%
fda ketamine pharma drug technology
Ascendis Pharma Announces Recommended Phase 2 Dose and Cohort Expansion for transcendIT-101, a Phase 1/2 Clinical Trial of TransCon™ TLR7/8 Agonist in Solid Tumors
Published: 2022-10-03 (Crawled : 13:00) - biospace.com/
ASND | $143.23 1.66% 26K
|
Health Technology
|
| O: 1.44%
H: 0.0%
C: -5.09%
it-101 expansion pharma trial phase 2
Sumitovant Biopharma and Sumitomo Pharma Announce Offer to Acquire Outstanding Shares of Myovant Sciences
Published: 2022-10-03 (Crawled : 09:00) - biospace.com/
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: 29.48%
H: 6.37%
C: 3.82%
biopharma pharma sciences acquire
Sumitovant Biopharma and Sumitomo Pharma Announce Offer to Acquire Outstanding Shares of Myovant Sciences
Published: 2022-10-02 (Crawled : 00:00) - prnewswire.com
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: 29.48%
H: 6.37%
C: 3.82%
biopharma pharma sciences acquire
Myovant Sciences Special Committee of Board Confirms Receipt of Preliminary, Non-binding Proposal from Sumitovant Biopharma and Sumitomo Pharma to Acquire Remaining Shares
Published: 2022-10-02 (Crawled : 00:00) - globenewswire.com
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: 29.48%
H: 6.37%
C: 3.82%
biopharma pharma sciences acquire proposal
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
Your saved searches
Save your searches and get alerts when important news are released.